SCHEMBL5268201

SCHEMBL5268201

Cc1cccc(N(C)C(=O)Nc2ccc(-c3c(C(N)=O)[nH]c4ccccc34)cc2)c1

nearest known ligand 0.52

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
KDR P35968 8/20 0.52
MAP2 P11137 7/20 0.51
PDGFRB P09619 3/20 0.51
IMPDH2 P12268 1/20 0.48
GAA P10253 1/20 0.41
KDM4E B2RXH2 2/20 0.40
ALDH1A1 P00352 2/20 0.40
HPGD P15428 2/20 0.40
MEN1 O00255 1/20 0.40
HTT P42858 1/20 0.40
GFER P55789 1/20 0.40
KMT2A Q03164 1/20 0.40
HSD17B10 Q99714 1/20 0.40
HSD17B1 P14061 1/20 0.40
HSD17B2 P37059 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3879349 0.83 KDR (0.73) KDRMAP2PDGFRBIMPDH2GAA
SCHEMBL3879937 0.80 KDR (0.55) KDRMAP2PDGFRBGAAKDM4E
SCHEMBL3884472 0.79 MAP2 (0.63) KDRMAP2PDGFRBGAAKDM4E
SCHEMBL3883071 0.78 KDR (0.60) KDRMAP2PDGFRBGAAKDM4E
SCHEMBL3880397 0.78 MAP2 (0.59) KDRMAP2PDGFRBGAAKDM4E
SCHEMBL5267110 0.77 MAP2 (0.57) KDRMAP2PDGFRBIMPDH2GAA
SCHEMBL3879170 0.75 MAP2 (0.72) KDRMAP2PDGFRBGAAKDM4E
SCHEMBL3877984 0.74 KDR (0.75) KDRMAP2PDGFRB
SCHEMBL10212285 0.74 KDR (0.57) KDRKDM4EHPGDMEN1KMT2A
SCHEMBL3883064 0.74 MAP2 (0.59) MAP2GAAKDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1841762-A1 SUBSTITUTED INDOLES, COMPOSITIONS CONTAINING THEM, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE Aventis Pharma S.A. (FR) 2007-10-10 EP claimed
WO-2006061493-A1 SUBSTITUTED INDOLES, COMPOSITIONS CONTAINING THEM, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AVENTIS PHARMA S.A. (FR) 2006-06-15 WO claimed
EP-1841762-A1 SUBSTITUTED INDOLES, COMPOSITIONS CONTAINING THEM, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE Aventis Pharma S.A. (FR) 2007-10-10 EP disclosed
WO-2006061493-A1 SUBSTITUTED INDOLES, COMPOSITIONS CONTAINING THEM, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AVENTIS PHARMA S.A. (FR) 2006-06-15 WO disclosed